SLEEP NUMBER CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.78 USD | -6.99% |
|
+5.42% | -0.34% |
| Apr. 25 | UBS Adjusts Sleep Number Price Target to $13 From $12, Maintains Neutral Rating | MT |
| Apr. 25 | Piper Sandler Adjusts Price Target on Sleep Number to $13 From $12, Keeps Neutral Rating | MT |
Strengths
- The company shows low valuation levels, with an enterprise value at 0.15 times its sales.
- The company has a low valuation given the cash flows generated by its activity.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Home Furnishings
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -0.34% | 355M | C | ||
| -3.06% | 8.79B | B | ||
| +5.46% | 4.07B | C- | ||
| +10.60% | 2.35B | C | ||
| -1.34% | 1.67B | - | ||
| -4.41% | 1.56B | B- | ||
| -27.65% | 1.16B | C+ | ||
| +12.58% | 1.04B | - | ||
| +18.79% | 1.03B | - | ||
| +6.89% | 924M | - |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- SNBR Stock
- Ratings Sleep Number Corporation
